These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3123277)

  • 1. Concomitant gonadotropin-releasing hormone agonist and menotropin treatment for the synchronized induction of multiple follicles.
    Palermo R; Amodeo G; Navot D; Rosenwaks Z; Cittadini E
    Fertil Steril; 1988 Feb; 49(2):290-5. PubMed ID: 3123277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term utilization of a gonadotropin-releasing hormone agonist (buserelin) for induction of ovulation in an in vitro fertilization program.
    Loumaye E; de Cooman S; Anoma M; Psalti I; Depreester S; Schmit M; Thomas K
    Ann N Y Acad Sci; 1988; 541():96-102. PubMed ID: 3143299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of ovarian response after suppression with a gonadotropin releasing hormone agonist in different chronological periods prior to gonadotropin stimulation for in vitro fertilization.
    Loutradis D; Kallianidis K; Sakellaropoulos G; Dokos J; Siskos K; Creatsas G; Deligeoroglou E; Michalas S; Aravantinos D
    Gynecol Obstet Invest; 1991; 32(2):68-71. PubMed ID: 1748325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.
    Yamashita T; Ishimaru T; Fujishita A; Kawano M; Yamabe T
    Hum Reprod; 1996 Aug; 11(8):1615-9. PubMed ID: 8921103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis.
    Nakamura K; Oosawa M; Kondou I; Inagaki S; Shibata H; Narita O; Suganuma N; Tomoda Y
    J Assist Reprod Genet; 1992 Apr; 9(2):113-7. PubMed ID: 1627925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT.
    Smitz J; Devroey P; Camus M; Khan I; Staessen C; Van Waesberghe L; Wisanto A; Van Steirteghem AC
    Hum Reprod; 1988 Oct; 3 Suppl 2():35-8. PubMed ID: 3147990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors promoting embryo implantation in in vitro fertilization and embryo transfer.
    Saito H; Sato F; Hirayama T; Saito T; Kawagoe S; Hiroi M
    Horm Res; 1992; 37 Suppl 1():64-8. PubMed ID: 1427632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program.
    Frydman R; Belaisch-Allart J; Parneix I; Forman R; Hazout A; Testart J
    Fertil Steril; 1988 Sep; 50(3):471-5. PubMed ID: 2970407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R
    J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reproductive outcome following a superhigh response to stimulation in gamete intrafallopian transfer program.
    al-Shawaf T; Nolan A; Nadkarni P; Harper J; Brown J; Guirgis R; Emerson G; Bayly M; Craft I
    J In Vitro Fert Embryo Transf; 1991 Aug; 8(4):202-7. PubMed ID: 1753165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between IVF and GIFT using the GnRH agonist protocol.
    Cittadini E; Palermo R; Agrifoglio V
    Acta Eur Fertil; 1988; 19(1):41-4. PubMed ID: 3137763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of long-term unexplained infertility with gonadotropin-releasing hormone agonist analogue and human menopausal gonadotropin.
    Aboulghar MA; Mansour RT; Serour GI
    Acta Obstet Gynecol Scand; 1990; 69(4):313-5. PubMed ID: 2123068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal nafarelin versus buserelin (short protocol) for controlled ovarian hyperstimulation before in vitro fertilization: a prospective clinical trial.
    Avrech OM; Goldman GA; Pinkas H; Amit S; Neri A; Zukerman Z; Ovadia J; Fisch B
    Gynecol Endocrinol; 1996 Jun; 10(3):165-70. PubMed ID: 8862491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined treatment with a GnRH-analog and gonadotropins in IVF-ET/GIFT patients after previously unsuccessful pure HMG stimulation].
    Urbancsek J; Rabe T; Grunwald K; Thuro H; Runnebaum B
    Zentralbl Gynakol; 1991; 113(10):563-74. PubMed ID: 1927104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined GnRH analogs/hMG/hCG treatment].
    Braendle W
    Arch Gynecol Obstet; 1989; 245(1-4):931-5. PubMed ID: 2529828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.